We are live on ! Find out more
SLNO

Soleno Therapeutics
SLNO

Delisted

SLNO was delisted on the 15th of May, 2026.

Back to rankings

33 hedge funds and large institutions have $48.5M invested in Soleno Therapeutics in 2020 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,200% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 1

60% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 5

57% more funds holding

Funds holding: 21 → 33 (+12)

0.45% more ownership

Funds ownership: 2.65% → 3.1% (+0.45%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

6% less capital invested

Capital invested by funds: $51.6M → $48.5M (-$3.03M)

Holders
33
Holders Change
+12
Holders Change %
+57.14%
% of All Funds
0.73%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
13
Increased
8
Reduced
5
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VC
Vivo Capital
California
+$5.73M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.2M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$1.09M
4
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$397K
5
Millennium Management
Millennium Management
New York
+$384K

Top Sellers

Rank Fund Capital Flow
1
BC
Birchview Capital
Vermont
-$877K
2
JGC
J. Goldman & Co
New York
-$191K
3
SAM
Shikiar Asset Management
New York
-$104K
4
6CM
683 Capital Management
New York
-$62.1K
5
Renaissance Technologies
Renaissance Technologies
New York
-$40.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
A
1
Abingworth
United Kingdom
$15.7M – – –
NCM
2
Nantahala Capital Management
Connecticut
$10.2M – – –
OIM
3
Oracle Investment Management
Connecticut
$9.21M – – –
VC
4
Vivo Capital
California
$4.81M +$5.73M +134,758 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$2.38M +$1.2M +28,165 +73%
TMC
6
Trellus Management Company
Florida
$1.06M – – –
6CM
7
683 Capital Management
New York
$952K -$62.1K -1,459 -5%
Point72 Asset Management
8
Point72 Asset Management
Connecticut
$916K +$1.09M +25,667 New
BC
9
Birchview Capital
Vermont
$480K -$877K -20,607 -61%
JGC
10
J. Goldman & Co
New York
$336K -$191K -4,479 -32%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$333K +$236K +5,551 +146%
BNP Paribas Financial Markets
12
BNP Paribas Financial Markets
France
$333K +$397K +9,328 New
Millennium Management
13
Millennium Management
New York
$322K +$384K +9,014 New
Renaissance Technologies
14
Renaissance Technologies
New York
$277K -$40.5K -953 -11%
BlackRock
15
BlackRock
New York
$205K +$49K +1,152 +25%
Susquehanna International Group
16
Susquehanna International Group
Pennsylvania
$184K +$174K +4,078 +378%
OC
17
Oppenheimer & Co
New York
$144K +$171K +4,021 New
Dimensional Fund Advisors
18
Dimensional Fund Advisors
Texas
$120K – – –
BBVA
19
Banco Bilbao Vizcaya Argentaria
Spain
$119K – – –
Northern Trust
20
Northern Trust
Illinois
$113K +$67.3K +1,581 +100%
Squarepoint
21
Squarepoint
New York
$98K +$117K +2,746 New
Goldman Sachs
22
Goldman Sachs
New York
$94K +$112K +2,622 New
ECM
23
ExodusPoint Capital Management
New York
$53K +$62.8K +1,476 New
Victory Capital Management
24
Victory Capital Management
Texas
$28K +$32.5K +763 New
AWM
25
AE Wealth Management
Kansas
$25K +$30.2K +709 New
1
2

SLNO Hedge Fund Activity: Q1 2020 in Review

33 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Soleno Therapeutics (SLNO) for Q1 2020, worth a combined $48.5M — down 5.9% from $51.6M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new SLNO positions and 1 closed out — a net gain of 12 holders — while 8 added to existing stakes and 5 trimmed.

The largest buyer was Vivo Capital, opening a new position worth an estimated $5.73M. The largest seller was Birchview Capital, cutting an estimated $877K.

  • 33 institutional investors held Soleno Therapeutics (SLNO) as of Q1 2020, up from 21 in Q4 2019.
  • Funds reported $48.5M of Soleno Therapeutics stock for Q1 2020, down 5.9% quarter-over-quarter.
  • 13 funds opened new Soleno Therapeutics positions in Q1 2020 and 1 closed out, a net change of +12 holders.
  • The largest Soleno Therapeutics buyer in Q1 2020 was Vivo Capital, an estimated $5.73M added.
  • The largest Soleno Therapeutics seller in Q1 2020 was Birchview Capital, an estimated $877K sold.

Based on aggregated 13F filings for Q1 2020.